Identifying prognostic markers in autism spectrum disorder using eye tracking.


Journal

Autism : the international journal of research and practice
ISSN: 1461-7005
Titre abrégé: Autism
Pays: England
ID NLM: 9713494

Informations de publication

Date de publication:
04 2020
Historique:
pubmed: 28 10 2019
medline: 25 6 2021
entrez: 25 10 2019
Statut: ppublish

Résumé

While many children with autism spectrum disorder are now detected at young ages given the rise in screening and general awareness, little is known regarding the prognosis of early detected children. The brain is shaped by experience-dependent mechanisms; thus, what a child pays attention to plays a pivotal role in shaping brain development. Eye tracking can provide an index of a child's visual attention and, as such, holds promise as a technology for revealing prognostic markers. In this, 49 children aged 1-3 years with autism spectrum disorder participated in an eye-tracking test, the GeoPref Test, that revealed preference for social versus nonsocial images. Next, children participated in a comprehensive test battery 5-9 years following the initial GeoPref Test. Statistical tests examined whether early age eye tracking predicted later school-age outcomes in symptom severity, social functioning, adaptive behavior, joint attention, and IQ. Results indicated that toddlers with higher preference for geometric images demonstrated greater symptom severity and fewer gaze shifts at school age. This relationship was not found in relation to IQ or adaptive behavior. Overall, the GeoPref Test holds promise as a symptom severity prognostic tool; further development of eye-tracking paradigms may enhance prognostic power and prove valuable in validating treatment progress.

Identifiants

pubmed: 31647314
doi: 10.1177/1362361319878578
pmc: PMC7166165
mid: NIHMS1539258
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

658-669

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH110558
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH080134
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH104446
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH036840
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH081755
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH118879
Pays : United States

Références

Pediatric Health Med Ther. 2015 May 19;6:65-78
pubmed: 29388581
J Neurosci. 2014 Oct 1;34(40):13349-63
pubmed: 25274814
Pediatrics. 2013 Apr;131(4):e1121-7
pubmed: 23530174
Pediatrics. 2015 Oct;136 Suppl 1:S1-9
pubmed: 26430167
Mol Autism. 2017 Jun 23;8:24
pubmed: 28649312
Autism. 2008 Sep;12(5):487-511
pubmed: 18805944
Dev Psychopathol. 2018 May;30(2):553-569
pubmed: 28803559
J Autism Dev Disord. 2015 Mar;45(3):778-94
pubmed: 25218848
Arch Gen Psychiatry. 2011 Jan;68(1):101-9
pubmed: 20819977
Neuron. 2015 Apr 22;86(2):567-77
pubmed: 25864635
J Consult Clin Psychol. 2008 Feb;76(1):125-37
pubmed: 18229990
Autism Res Treat. 2014;2014:964704
pubmed: 24711926
J Am Acad Child Adolesc Psychiatry. 2012 May;51(5):487-95
pubmed: 22525955
Mol Autism. 2018 Mar 21;9:19
pubmed: 29581878
Biol Psychiatry. 2016 Apr 15;79(8):657-66
pubmed: 25981170
Curr Biol. 2015 Jun 29;25(13):1727-30
pubmed: 26073135
J Autism Dev Disord. 2009 Jan;39(1):23-41
pubmed: 18535894
J Autism Dev Disord. 2013 Feb;43(2):418-31
pubmed: 22733301
Curr Opin Neurobiol. 2005 Apr;15(2):225-30
pubmed: 15831407
Neurosci Bull. 2017 Apr;33(2):183-193
pubmed: 28213805
J Child Psychol Psychiatry. 2013 Feb;54(2):216-24
pubmed: 22823182
Pediatrics. 2011 May;127(5):e1303-11
pubmed: 21464190
J Neurosci. 2016 Feb 3;36(5):1620-30
pubmed: 26843643
Mol Psychiatry. 2019 Jan;24(1):88-107
pubmed: 29934544
Nat Neurosci. 2015 Feb;18(2):302-9
pubmed: 25599222
Brain Res Rev. 2009 May;60(2):287-305
pubmed: 19162072
J Child Psychol Psychiatry. 2018 Aug;59(8):872-880
pubmed: 29359802
J Pediatr. 2011 Sep;159(3):458-465.e1-6
pubmed: 21524759
Pediatrics. 2014 Jan;133(1):37-45
pubmed: 24366990
Neuropsychol Rev. 2008 Dec;18(4):339-66
pubmed: 19009353
J Child Psychol Psychiatry. 2014 May;55(5):485-94
pubmed: 24313878
Autism Res. 2018 Jan;11(1):166-174
pubmed: 29193826
Nature. 2017 Jul 20;547(7663):340-344
pubmed: 28700580
Nat Rev Neurol. 2014 Feb;10(2):74-81
pubmed: 24468882
Dev Psychopathol. 2008 Summer;20(3):775-803
pubmed: 18606031
Arch Gen Psychiatry. 2002 Sep;59(9):809-16
pubmed: 12215080
Am J Intellect Dev Disabil. 2009 Jan;114(1):23-41
pubmed: 19143460
Autism Res. 2018 Jan;11(1):121-132
pubmed: 29076255

Auteurs

Elizabeth C Bacon (EC)

University of California San Diego, USA.

Adrienne Moore (A)

University of California San Diego, USA.

Quimby Lee (Q)

University of California San Diego, USA.

Cynthia Carter Barnes (C)

University of California San Diego, USA.

Eric Courchesne (E)

University of California San Diego, USA.

Karen Pierce (K)

University of California San Diego, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH